Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis

Shu Yi Yin, Feng Yin Jian, Yung Hsiang Chen, Shih Chang Chien, Mao Chih Hsieh, Pei Wen Hsiao, Wen Hwa Lee, Yueh Hsiung Kuo, Ning Sun Yang

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Tumour-associated fibroblasts (TAFs), as a functionally supportive microenvironment, play an essential role in tumour progression. Here we investigate the role of IL-25, an endogenous anticancer factor secreted from TAFs, in suppression of mouse 4T1 mammary tumour metastasis. We show that a synthetic dihydrobenzofuran lignan (Q2-3), the dimerization product of plant caffeic acid methyl ester, suppresses 4T1 metastasis by increasing fibroblastic IL-25 activity. The secretion of IL-25 from treated human or mouse fibroblasts is enhanced in vitro, and this activity confers a strong suppressive effect on growth activity of test carcinoma cells. Subsequent in vivo experiments showed that the anti-metastatic effects of Q2-3 on 4T1 and human MDA-MD-231 tumour cells are additive when employed in combination with the clinically used drug, docetaxel. Altogether, our findings reveal that the release of IL-25 from TAFs may serve as a check point for control of mammary tumour metastasis and that phytochemical Q2-3 can efficiently promote such anticancer activities.

Original languageEnglish
Article number11311
JournalNature Communications
Volume7
DOIs
Publication statusPublished - Apr 18 2016

Fingerprint

secretions
fibroblasts
metastasis
Fibroblasts
Tumors
induction
tumors
docetaxel
Breast Neoplasms
Neoplasm Metastasis
Lignans
Phytochemicals
Dimerization
Neoplasms
mice
Carcinoma
Cells
multiple docking adapters
Growth
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Chemistry(all)
  • Physics and Astronomy(all)

Cite this

Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis. / Yin, Shu Yi; Jian, Feng Yin; Chen, Yung Hsiang; Chien, Shih Chang; Hsieh, Mao Chih; Hsiao, Pei Wen; Lee, Wen Hwa; Kuo, Yueh Hsiung; Yang, Ning Sun.

In: Nature Communications, Vol. 7, 11311, 18.04.2016.

Research output: Contribution to journalArticle

Yin, Shu Yi ; Jian, Feng Yin ; Chen, Yung Hsiang ; Chien, Shih Chang ; Hsieh, Mao Chih ; Hsiao, Pei Wen ; Lee, Wen Hwa ; Kuo, Yueh Hsiung ; Yang, Ning Sun. / Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis. In: Nature Communications. 2016 ; Vol. 7.
@article{81cedd4aade84e0cbdcd393616ab30dd,
title = "Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis",
abstract = "Tumour-associated fibroblasts (TAFs), as a functionally supportive microenvironment, play an essential role in tumour progression. Here we investigate the role of IL-25, an endogenous anticancer factor secreted from TAFs, in suppression of mouse 4T1 mammary tumour metastasis. We show that a synthetic dihydrobenzofuran lignan (Q2-3), the dimerization product of plant caffeic acid methyl ester, suppresses 4T1 metastasis by increasing fibroblastic IL-25 activity. The secretion of IL-25 from treated human or mouse fibroblasts is enhanced in vitro, and this activity confers a strong suppressive effect on growth activity of test carcinoma cells. Subsequent in vivo experiments showed that the anti-metastatic effects of Q2-3 on 4T1 and human MDA-MD-231 tumour cells are additive when employed in combination with the clinically used drug, docetaxel. Altogether, our findings reveal that the release of IL-25 from TAFs may serve as a check point for control of mammary tumour metastasis and that phytochemical Q2-3 can efficiently promote such anticancer activities.",
author = "Yin, {Shu Yi} and Jian, {Feng Yin} and Chen, {Yung Hsiang} and Chien, {Shih Chang} and Hsieh, {Mao Chih} and Hsiao, {Pei Wen} and Lee, {Wen Hwa} and Kuo, {Yueh Hsiung} and Yang, {Ning Sun}",
year = "2016",
month = "4",
day = "18",
doi = "10.1038/ncomms11311",
language = "English",
volume = "7",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis

AU - Yin, Shu Yi

AU - Jian, Feng Yin

AU - Chen, Yung Hsiang

AU - Chien, Shih Chang

AU - Hsieh, Mao Chih

AU - Hsiao, Pei Wen

AU - Lee, Wen Hwa

AU - Kuo, Yueh Hsiung

AU - Yang, Ning Sun

PY - 2016/4/18

Y1 - 2016/4/18

N2 - Tumour-associated fibroblasts (TAFs), as a functionally supportive microenvironment, play an essential role in tumour progression. Here we investigate the role of IL-25, an endogenous anticancer factor secreted from TAFs, in suppression of mouse 4T1 mammary tumour metastasis. We show that a synthetic dihydrobenzofuran lignan (Q2-3), the dimerization product of plant caffeic acid methyl ester, suppresses 4T1 metastasis by increasing fibroblastic IL-25 activity. The secretion of IL-25 from treated human or mouse fibroblasts is enhanced in vitro, and this activity confers a strong suppressive effect on growth activity of test carcinoma cells. Subsequent in vivo experiments showed that the anti-metastatic effects of Q2-3 on 4T1 and human MDA-MD-231 tumour cells are additive when employed in combination with the clinically used drug, docetaxel. Altogether, our findings reveal that the release of IL-25 from TAFs may serve as a check point for control of mammary tumour metastasis and that phytochemical Q2-3 can efficiently promote such anticancer activities.

AB - Tumour-associated fibroblasts (TAFs), as a functionally supportive microenvironment, play an essential role in tumour progression. Here we investigate the role of IL-25, an endogenous anticancer factor secreted from TAFs, in suppression of mouse 4T1 mammary tumour metastasis. We show that a synthetic dihydrobenzofuran lignan (Q2-3), the dimerization product of plant caffeic acid methyl ester, suppresses 4T1 metastasis by increasing fibroblastic IL-25 activity. The secretion of IL-25 from treated human or mouse fibroblasts is enhanced in vitro, and this activity confers a strong suppressive effect on growth activity of test carcinoma cells. Subsequent in vivo experiments showed that the anti-metastatic effects of Q2-3 on 4T1 and human MDA-MD-231 tumour cells are additive when employed in combination with the clinically used drug, docetaxel. Altogether, our findings reveal that the release of IL-25 from TAFs may serve as a check point for control of mammary tumour metastasis and that phytochemical Q2-3 can efficiently promote such anticancer activities.

UR - http://www.scopus.com/inward/record.url?scp=84973326038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973326038&partnerID=8YFLogxK

U2 - 10.1038/ncomms11311

DO - 10.1038/ncomms11311

M3 - Article

C2 - 27089063

AN - SCOPUS:84973326038

VL - 7

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 11311

ER -